Nevro Corp.
NVRO

$158.5 M
Marketcap
$4.23
Share price
Country
$0.13
Change (1 day)
$22.64
Year High
$3.95
Year Low
Categories

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.

marketcap

Revenue of Nevro Corp. (NVRO)

Revenue in 2023 (TTM): $425.17 M

According to Nevro Corp.'s latest financial reports the company's current revenue (TTM) is $425.17 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history of Nevro Corp.

Annual Revenue

Year Revenue Gross Profit Ebitda Income Before Tax Net Income
2023 $425.17 M $290.06 M $-78,310,000 $-97,859,000 $-92,213,000
2022 $406.37 M $276.37 M $21.02 M $4.26 M $3 M
2021 $386.91 M $266.04 M $-102,399,000 $-130,826,000 $-131,360,000
2020 $362.05 M $249.9 M $-52,205,000 $-82,197,000 $-83,065,000
2019 $390.26 M $268.35 M $-83,356,000 $-102,087,000 $-103,686,000
2018 $387.29 M $273.32 M $-37,856,000 $-48,437,000 $-49,205,000
2017 $326.67 M $227.69 M $-22,841,000 $-35,250,000 $-36,658,000
2016 $228.5 M $153.07 M $-22,044,000 $-30,155,000 $-31,778,000
2015 $69.61 M $41.49 M $-62,919,000 $-66,265,000 $-67,431,000
2014 $32.57 M $21.3 M $-30,090,000 $-30,202,000 $-30,680,000
2013 $23.5 M $14.03 M $-25,104,000 $-25,652,000 $-26,014,000
2012 $18.15 M $10.62 M $-19,091,000 $-18,805,000 $-18,967,000